Cancer Treatment News and Research

RSS

Oncology pharmacists play a major role in treating cancer patients

One of the hallmarks of a National Cancer Institute-designated Comprehensive Cancer Center like Rutgers Cancer Institute of New Jersey, the only such designated center in the state, is the unique oncology expertise exhibited by its clinical team.

18 Oct 2019

Transatlantic research alliance aims to develop radical new strategies for early cancer detection

Developing radical new strategies and technologies to detect cancer at its earliest stage is the bold ambition of a new transatlantic research alliance, announced today (Monday) by Cancer Research UK and partners.

18 Oct 2019

Yale scientists build powerful genomic research platform to study cervical cancer

Yale Cancer Center scientists have built a powerful genomic research platform to study cervical cancer, a disease that often is untreatable if it progresses after surgery or primary chemo-radiation treatment.

17 Oct 2019

MD Anderson and Varian announce strategic collaboration to optimize radiation oncology treatment

The University of Texas MD Anderson Cancer Center and Varian today announced a new strategic collaboration to develop an integrated software platform to streamline review of radiation oncology treatment plans.

17 Oct 2019

New guidance from oncology experts recommends tailored exercise prescriptions

New guidance from exercise oncology experts recommend systematic use of an "exercise prescription" by health care workers and fitness professionals in designing and delivering exercise programs that aim to lower the risk of developing certain cancers and best meet the needs, preferences and abilities of people with cancer.

17 Oct 2019

New recommendations outline specific 'exercise prescriptions' for cancer survivors

A recent review of research, conducted by an international group of experts led by the University of British Columbia, has resulted in the development of new exercise guidelines for cancer survivors.

16 Oct 2019

Scientists harness the power of immune system to test novel cancer treatment

The field of immunotherapy has revolutionized the way people with incurable cancers are treated, saving the lives of many people whose disease would have otherwise been seen as a death sentence. Despite its success in treating people with deadly forms of leukemia and lymphoma, there are still many people who do not benefit from the treatment or eventually experience a relapse of their cancer.

16 Oct 2019

UTEP awarded $19.2 million NIH grant to study cancer affecting Mexican-American population

The University of Texas at El Paso's Border Biomedical Research Center will accelerate its quest to understand and identify the reasons for Hispanic cancer health disparities and its ultimate impact on the people of the Paso del Norte region thanks to a five-year, $19.2 million grant from the National Institutes of Health.

16 Oct 2019

Researchers outline new exercise recommendations for people living with and beyond cancer

It's well known that exercise is good for preventing and treating many forms of heart disease, but less commonly known are the benefits of physical activity for people living with and beyond cancer.

16 Oct 2019

New guidance recommends systematic use of 'exercise prescription' for cancer patients

A global panel of exercise oncology experts today published new guidance recommending the systematic use of an “exercise prescription” to help cancer patients cope with treatment side effects and lower the risk of developing certain cancers.

15 Oct 2019

New cancer treatment developed at Yale

Scientists at Yale have developed a method that assists the immune system in identifying and eliminating cancer cells that may be missed by other forms of immunotherapies.

15 Oct 2019

UH Rainbow awarded $3 million to establish Pediatric Disaster Care Center of Excellence

The U.S. Department of Health and Human Services' Office of the Assistant Secretary of Preparedness and Response awarded $3 million to University Hospitals Rainbow Babies & Children's Hospital to establish a Pediatric Disaster Care Center of Excellence.

14 Oct 2019

NCI awards $1.87 million grant to help patients navigate costs of cancer care

The National Cancer Institute has awarded a four-year, more than $1.87 million grant to University of North Carolina Lineberger Comprehensive Cancer Center researchers to study the impact of implementing financial navigation services at five rural cancer centers in North Carolina to help patients cope with the financial burden, or financial toxicity, related to cancer care.

14 Oct 2019

$RESILIENT study tests benefit of ETA guided treatments for patients with advanced refractory cancers$

RESILIENT study tests benefit of ETA guided treatments for patients with advanced refractory cancers

RESILIENT was a single arm, open label, phase II/III study to test if label agnostic therapy regimens guided by Encyclopedic Tumor Analysis can offer meaningful clinical benefit for patients with relapsed refractory metastatic malignancies.

11 Oct 2019

Vaccine against gastrin may slow spread of pancreatic cancer

New research suggests a vaccine that blocks a digestive hormone may slow the spread of pancreatic cancer, potentially increasing survival rates. The study, published ahead of print in the American Journal of Physiology—Gastrointestinal and Liver Physiology, was chosen as an APSselect article for October.

10 Oct 2019

Hormone therapy worsens quality of life in women with breast cancer

Analysis of the CANTO cohort published in the journal Annals of Oncology will upset received wisdom on the effects that hormone therapy and chemotherapy have on the quality of life in women with breast cancer. Contrary to the commonly held view, 2 years after diagnosis, hormone therapy, a highly effective breast cancer treatment worsens quality of life to a greater extent and for a longer time, especially in menopausal patients.

8 Oct 2019

Study receives NCI grant to explore better treatment for brain tumors in children

Children with recurrent brain tumors or newly diagnosed, particularly aggressive tumors called diffuse intrinsic pontine gliomas are being enrolled in the first study to examine the efficacy of a drug that inhibits an enzyme these tumors use to protect themselves from the child's natural immune response.

8 Oct 2019

Cancer Treatment News and Research

Oncology pharmacists play a major role in treating cancer patients

Transatlantic research alliance aims to develop radical new strategies for early cancer detection

Yale scientists build powerful genomic research platform to study cervical cancer

MD Anderson and Varian announce strategic collaboration to optimize radiation oncology treatment

New guidance from oncology experts recommends tailored exercise prescriptions

New recommendations outline specific 'exercise prescriptions' for cancer survivors

Scientists harness the power of immune system to test novel cancer treatment

UTEP awarded $19.2 million NIH grant to study cancer affecting Mexican-American population

Researchers outline new exercise recommendations for people living with and beyond cancer

New guidance recommends systematic use of 'exercise prescription' for cancer patients

New cancer treatment developed at Yale

UH Rainbow awarded $3 million to establish Pediatric Disaster Care Center of Excellence

NCI awards $1.87 million grant to help patients navigate costs of cancer care

RESILIENT study tests benefit of ETA guided treatments for patients with advanced refractory cancers

Vaccine against gastrin may slow spread of pancreatic cancer

Hormone therapy worsens quality of life in women with breast cancer

Study receives NCI grant to explore better treatment for brain tumors in children

New device can accelerate bone regeneration in difficult cases

Exercise can help protect cancer patients' heart from negative effects of therapies

Exercise may help reduce heart damage caused by chemotherapy

Industry Focus eBook - Cell & Gene Therapy (1st Edition) eBook

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News